Genome-wide linkage analysis replicates susceptibility locus for fasting plasma triglycerides: NHLBI Family Heart Study

Human Genetics

Volumn 115, Issue 6, 2004, Pages 468-474

  Arnett, Donna K ^a   Miller, Michael B ^a   Coon, Hilary ^b   Ellison, R Curtis ^c   North, Kari E ^d   Province, Michael ^e   Leppert, Mark ^b   Eckfeldt, John H ^f  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHROMOSOME 15; CHROMOSOME 6; CHROMOSOME 8; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DNA REPLICATION; FAMILY STUDY; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; VARIANCE;

CHROMOSOME MAPPING; CHROMOSOMES; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; FAMILY HEALTH; FASTING; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPE; HUMANS; LIKELIHOOD FUNCTIONS; LINKAGE (GENETICS); LIPOPROTEINS, HDL; LOD SCORE; MALE; PHENOTYPE; QUANTITATIVE TRAIT LOCI; TRIGLYCERIDES;

MAMMALIA;

EID: 9444219705     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-004-1182-y     Document Type: Article

References (29)

1. Arnett DK, Pankow JS, Atwood LD, Sellers TA (1997) Impact of adjustments for intermediate phenotypes on the power to detect linkage. Genet Epidemiol 14:749-754 10.1002/(SICI)1098-2272(1997)14:6<749::AID-GEPI31>3.3.CO;2-I, 1:STN:280:DyaK1c%2FpsFeksg%3D%3D, 9433572
2. Austin MA (1998) Plasma triglyceride as a risk factor for cardiovascular disease. Can J Cardiol 14(suppl B):14B-317B 1:CAS:528:DyaK1cXktVCmtbk%3D, 9627537
3. Austin MA, King MC, Bawol RD, Hulley SB, Friedman GD (1987) Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol 125:308-318 1:STN:280:BiiC38vnsFw%3D, 3812436
4. Breslow JL (2000) Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu Rev Genet 34:233-254 10.1146/annurev.genet.34.1.233, 1:CAS:528:DC%2BD3MXlvFKqtw%3D%3D, 11092828
5. Coon H, Leppert MF, Eckfeldt JH, Oberman A, Myers RH, Peacock JM, Province MA, Hopkins PN, Heiss G (2001) Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) blood pressure study. Arterioscler Thromb Vasc Biol 21:1969-1976 1:CAS:528:DC%2BD38XjtVWg, 11742872
6. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, O'Connell P, Stern MP (2000) A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. Am J Hum Genet 66:1237-1245 10.1086/302849, 1:CAS:528:DC%2BD3cXntV2isrk%3D, 10729112
7. Elbein SC, Hasstedt SJ (2002) Quantitative trait linkage analysis of lipid-related traits in familial type 2 diabetes: Evidence for linkage of triglyceride levels to chromosome 19q. Diabetes 51:528-535 1:CAS:528:DC%2BD38XhtVejsrY%3D, 11812765
8. Feitosa MF, Borecki IB, Rich SS, Arnett DK, Sholinsky P, Myers RH, Leppert M, Province MA (2002) Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: The National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 70:72-82 10.1086/338144, 1:CAS:528:DC%2BD38XlvVKgsw%3D%3D, 11713718
9. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359 10.1001/jama.287.3.356, 11790215
10. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka JM, Williams R (1996) NHLBI Family Heart Study: Objectives and design. Am J Epidemiol 143:1219-1228 1:STN:280:BymB2crgvFc%3D, 8651220
11. Hinds D, Risch N (1996) The ASPEX package: Affected sib-pair exclusion mapping [computer program]. Stanford University, Stanford
12. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Fuller JH, Bennett PH, Hanson RL (2000) A locus influencing total serum cholesterol on chromosome 19p: Results from an autosomal genomic scan of serum lipid concentrations in Pima Indians. Arterioscler Thromb Vasc Biol 20:2651-2656 1:CAS:528:DC%2BD3MXitlWhsw%3D%3D, 11116067
13. Klos KL, Kardia SL, Ferrell RE, Turner ST, Boerwinkle E, Sing CF (2001) Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease. Arterioscler Thromb Vasc Biol 21:971-978 1:CAS:528:DC%2BD3MXksVart7Y%3D, 11397706
14. Kuller LH, Simkin-Silverman LR, Wing RR, Meilahn EN, Ives DG (2001) Women's Healthy LifestyRe Project: A randomized clinical trial: results at 54 months. Circulation 103:32-37 1:STN:280:DC%2BD3M%2FovVSjsQ%3D%3D, 11136682
15. Naoumova RP, Bonney SA, Eichenbaum-Voline S, Patel HN, Jones B, Jones EL, Amey J, Colilla S, Neuwirth CK, Allotey R, Seed M, Betteridge DJ, Galton DJ, Cox NJ, Bell GI, Scott J, Shoulders CC (2003) Confirmed locus on chromosome 11p and candidate loci on 6q and 8p for the triglyceride and cholesterol traits of combined hyperlipidemia. Arterioscler Thromb Vasc Biol 23:2070-2077 10.1161/01.ATV.0000095975.35247.9F, 1:CAS:528:DC%2BD3sXoslWksb4%3D, 14500288
16. Newman DL, Abney M, Dytch H, Parry R, McPeek MS, Ober C (2003) Major loci influencing serum triglyceride levels on 2q14 and 9p21 localized by homozygosity-by-descent mapping in a large Hutterite pedigree. Hum Mol Genet 12:137-144 10.1093/hmg/ddg012, 1:CAS:528:DC%2BD3sXks1OhtA%3D%3D, 12499394
17. Pajukanta P, Terwilliger JD, Perola M, Hiekkalinna T, Nuotio I, Ellonen P, Parkkonen M, Hartiala J, Ylitalo K, Pihlajamaki J, Porkka K, Laakso M, Viikari J, Ehnholm C, Taskinen MR, Peltonen L (1999) Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet 64:1453-1463 10.1086/302365, 1:CAS:528:DyaK1MXlt1ajt7c%3D, 10205279
18. PEDSYS (1999) Southwest Foundation for Biomedical Research, San Antonio, edn. 2.0
19. Perusse L, Rice T, Despres JP, Bergeron J, Province MA, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C (1997) Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE family study. Arterioscler Thromb Vasc Biol 17:3263-3269 1:CAS:528:DyaK1cXisV2mtA%3D%3D, 9409321
20. Pratt SC, Daly MJ, Kruglyak L (2000) Exact multipoint quantitative-trait linkage analysis in pedigrees by variance components. Am J Hum Genet 66:1153-1157 10.1086/302830, 1:CAS:528:DC%2BD3cXisFSht7w%3D, 10712227
21. Rashid S, Trinh DK, Uffelman KD, Cohn JS, Rader DJ, Lewis GF (2003) Expression of human hepatic lipase in the rabbit model preferentially enhances the clearance of triglyceride-enriched versus native high-density lipoprotein apolipoprotein A-I. Circulation 107:3066-3072 10.1161/01.CIR.0000070947.64595.47, 1:CAS:528:DC%2BD3sXksF2nur4%3D, 12796142
22. Rodriguez C, Pablos-Mendez A, Palmas W, Lantigua R, Mayeux R, Berglund L (2002) Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians > or =65 years of age living in New York city. Am J Cardiol 89:178-183 10.1016/S0002-9149(01)02197-X, 1:CAS:528:DC%2BD38XktFektQ%3D%3D, 11792339
23. Shearman AM, Ordovas JM, Cupples LA, Schaefer EJ, Harmon MD, Shao Y, Keen JD, DeStefano AL, Joost O, Wilson PW, Housman DE, Myers RH (2000) Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: A genome-wide scan in the Framingham study. Hum Mol Genet 9:1315-1320 10.1093/hmg/9.9.1315, 1:CAS:528:DC%2BD3cXjvFynu7c%3D, 10814713
24. Shoji T, Ishimura E, Inaba M, Tabata T, Nishizawa Y (2001) Atherogenic lipoproteins in end-stage renal disease. Am J Kidney Dis 38:S30-S33 1:CAS:528:DC%2BD3MXnslKgsbo%3D, 11576918
25. Suter PM, Gerritsen-Zehnder M, Hasler E, Gurtler M, Vetter W, Hanseler E (2001) Effect of alcohol on postprandial lipemia with and without preprandial exercise. J Am Coll Nutr 20:58-64 1:CAS:528:DC%2BD3MXivV2lsbg%3D, 11293469
26. The Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 273:199-208 7807658
27. Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863-870 1:CAS:528:DyaK2MXnsVSnsbo%3D, 7621989
28. Warnick GR, Benderson J, Albers JJ (1982) Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28:1379-1388 1:CAS:528:DyaL38Xks1yrtbs%3D, 7074948
29. Weber JL, Broman KW (2001) Genotyping for human whole-genome scans: past, present, and future. Adv Genet 42:77-96 10.1016/S0065-2660(01)42016-5, 1:CAS:528:DC%2BD3cXot1Smtrs%3D, 11037315